{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T23:00:56Z","timestamp":1778367656477,"version":"3.51.4"},"reference-count":154,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Severe burn injury poses significant clinical challenges, often necessitating the use of vasoactive agents to maintain perfusion. This narrative review explores the current landscape of vasoactive agents in acute burn shock resuscitation and in severe burn-injured patients who develop septic shock, with a particular focus on the potential role of the novel vasoactive agent, synthetic angiotensin-II (AT-II), in these settings. While catecholamines and vasopressin remain cornerstone therapies, adverse effects, variable patient responses, and a new understanding of burn injury pathophysiology highlight the potentially evolving role of vasoactive agents in these clinical scenarios. A key system involved in blood pressure regulation, the renin-angiotensin-aldosterone system, is often dysregulated in acute burn and septic shock. Contributory mechanisms and potential benefits of synthetic AT-II are discussed here and form the physiologic rationale behind the exogenous administration of synthetic AT-II in the context of available safety and efficacy data. To date, administration of synthetic AT-II has shown promise in improving hemodynamics and clinical outcomes in distributive shock populations; however, data in acute burn shock and in burn patients who develop septic shock are lacking. In addition, a comprehensive understanding of the potential and future areas of research in burn shock and severe burn-injured patients is provided.<\/jats:p>","DOI":"10.1093\/jbcr\/irae208","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:31:57Z","timestamp":1733938317000},"page":"515-525","source":"Crossref","is-referenced-by-count":3,"title":["Vasoactive Agents in Burn Patients: Perspectives on Angiotensin-II"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1238-8199","authenticated-orcid":false,"given":"Scott W","family":"Mueller","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Colorado Health , Aurora, CO ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas M","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tampa General Hospital , Tampa, FL ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6007-359X","authenticated-orcid":false,"given":"Kevin D","family":"Betthauser","sequence":"additional","affiliation":[{"name":"Innoviva Specialty Therapeutics , Waltham, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3385-8105","authenticated-orcid":false,"given":"Mitchell S","family":"Buckley","sequence":"additional","affiliation":[{"name":"Innoviva Specialty Therapeutics , Waltham, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Shupp","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular and Cellular Biology, Georgetown University Medical Center , Washington, DC ,","place":["United States"]},{"name":"MedStar Health Research Institute, Firefighters\u2019 Burn and Surgical Research Laboratory , Washington, DC ,","place":["United States"]},{"name":"Department of Surgery, MedStar Washington Hospital Center, The Burn Center , Washington, DC ,","place":["United States"]},{"name":"Department of Surgery, Georgetown University School of Medicine , Washington, DC ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arek J","family":"Wiktor","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Colorado School of Medicine , Aurora, CO ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1119-1901","authenticated-orcid":false,"given":"David M","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Regional One Health , Memphis, TN ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"2025081301371269700_CIT0001"},{"key":"2025081301371269700_CIT0002","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.burns.2011.07.017","article-title":"Prognostic scoring systems in burns: a review","volume":"37","author":"Sheppard","year":"2011","journal-title":"Burns"},{"key":"2025081301371269700_CIT0003","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMra1208943","article-title":"Circulatory shock","volume":"369","author":"Vincent","year":"2013","journal-title":"N Engl J Med"},{"key":"2025081301371269700_CIT0004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-020-0145-5","article-title":"Burn injury","volume":"6","author":"Jeschke","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2025081301371269700_CIT0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.burns.2020.09.005","article-title":"The use of vasopressors during acute burn resuscitation","volume":"47","author":"Adibfar","year":"2021","journal-title":"Burns"},{"key":"2025081301371269700_CIT0006","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/BCR.0b013e3181599bc9","article-title":"American burn association consensus conference to define sepsis and infection in burns","volume":"28","author":"Greenhalgh","year":"2007","journal-title":"J Burn Care Res"},{"key":"2025081301371269700_CIT0007","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.burns.2023.05.003","article-title":"Surviving sepsis after burn campaign","volume":"49","author":"Greenhalgh","year":"2023","journal-title":"Burns"},{"key":"2025081301371269700_CIT0008","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.TA.0000029382.26295.AB","article-title":"The risk factors and time course of sepsis and organ dysfunction after burn trauma","volume":"54","author":"Fitzwater","year":"2003","journal-title":"J Trauma"},{"key":"2025081301371269700_CIT0009","doi-asserted-by":"crossref","first-page":"tkaa047","DOI":"10.1093\/burnst\/tkaa047","article-title":"The pathogenesis and diagnosis of sepsis post burn injury","volume":"9","author":"Zhang","year":"2021","journal-title":"Burns Trauma"},{"key":"2025081301371269700_CIT0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jbcr\/irac025","article-title":"Burn shock and resuscitation: review and state of the science","volume":"43","author":"Cartotto","year":"2022","journal-title":"J Burn Care Res"},{"key":"2025081301371269700_CIT0011","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/BCR.0b013e31815f3876","article-title":"American Burn Association practice guidelines burn shock resuscitation","volume":"29","author":"Pham","year":"2008","journal-title":"J Burn Care Res"},{"key":"2025081301371269700_CIT0012","first-page":"253","article-title":"Management of severe thermal burns in the acute phase in adults and children","volume":"39","author":"Legrand","year":"2020","journal-title":"Anaesth Crit Care Pain Med"},{"key":"2025081301371269700_CIT0013","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.burns.2016.05.013","article-title":"ISBI practice guidelines for burn care","volume":"42","author":"Committee","year":"2016","journal-title":"Burns"},{"key":"2025081301371269700_CIT0014","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jbcr\/irad125","article-title":"American Burn Association clinical practice guidelines on burn shock resuscitation","volume":"45","author":"Cartotto","year":"2024","journal-title":"J Burn Care Res"},{"key":"2025081301371269700_CIT0015","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00134-019-05801-z","article-title":"Vasopressor therapy in critically ill patients with shock","volume":"45","author":"Russell","year":"2019","journal-title":"Intensive Care Med"},{"key":"2025081301371269700_CIT0016","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/phar.2199","article-title":"Catecholamine vasopressor support sparing strategies in vasodilatory shock","volume":"39","author":"Buckley","year":"2019","journal-title":"Pharmacotherapy"},{"key":"2025081301371269700_CIT0017","doi-asserted-by":"crossref","first-page":"e029787","DOI":"10.1161\/JAHA.123.029787","article-title":"State of shock: contemporary vasopressor and inotrope use in cardiogenic shock","volume":"12","author":"Bloom","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2025081301371269700_CIT0018","first-page":"e238119","article-title":"Management of cardiogenic shock: present and future","volume":"50","author":"Diakos","year":"2023","journal-title":"Tex Heart Inst J"},{"key":"2025081301371269700_CIT0019","doi-asserted-by":"crossref","first-page":"e011991","DOI":"10.1161\/JAHA.119.011991","article-title":"Cardiogenic shock","volume":"8","author":"Vahdatpour","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025081301371269700_CIT0020","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and NE in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"2025081301371269700_CIT0021","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/SHK.0000000000001390","article-title":"Temporal trends and clinical outcomes associated with vasopressor and inotrope use in the cardiac intensive care unit","volume":"53","author":"Jentzer","year":"2020","journal-title":"Shock"},{"key":"2025081301371269700_CIT0022","first-page":"52","article-title":"Experts\u2019 recommendations for the management of adult patients with cardiogenic shock","volume":"5","author":"Levy","year":"2015","journal-title":"Ann Intensive Care"},{"key":"2025081301371269700_CIT0023","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025081301371269700_CIT0024","doi-asserted-by":"crossref","first-page":"1300839","DOI":"10.3389\/fcvm.2023.1300839","article-title":"Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database","volume":"10","author":"Sasmita","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2025081301371269700_CIT0025","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"2025081301371269700_CIT0026","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0b013e31823778ee","article-title":"Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis","volume":"40","author":"De Backer","year":"2012","journal-title":"Crit Care Med"},{"key":"2025081301371269700_CIT0027","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13613-018-0448-9","article-title":"Mean arterial pressure and mortality in patients with distributive shock: a retrospective analysis of the mimic-iii database","volume":"8","author":"Vincent","year":"2018","journal-title":"Ann Intensive Care"},{"key":"2025081301371269700_CIT0028","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1378\/chest.12-1106","article-title":"Survival after shock requiring high-dose vasopressor therapy","volume":"143","author":"Brown","year":"2013","journal-title":"Chest"},{"key":"2025081301371269700_CIT0029","doi-asserted-by":"crossref","first-page":"R181","DOI":"10.1186\/cc8167","article-title":"Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial","volume":"13","author":"Dunser","year":"2009","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","article-title":"Norepinephrine: not too much, too long","volume":"44","author":"Martin","year":"2015","journal-title":"Shock"},{"key":"2025081301371269700_CIT0031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcrc.2013.09.004","article-title":"Does high-dose vasopressor therapy in medical intensive care patients indicate what we already suspect","volume":"29","author":"Sviri","year":"2014","journal-title":"J Crit Care"},{"key":"2025081301371269700_CIT0032","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13613-018-0379-5","article-title":"Predictors of response to fixed-dose vasopressin in adult patients with septic shock","volume":"8","author":"Sacha","year":"2018","journal-title":"Ann Intensive Care"},{"key":"2025081301371269700_CIT0033","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/phar.2683","article-title":"Machine learning to predict vasopressin responsiveness in patients with septic shock","volume":"42","author":"Scheibner","year":"2022","journal-title":"Pharmacotherapy"},{"key":"2025081301371269700_CIT0034","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II infusion for shock: a multicenter study of postmarketing use","volume":"159","author":"Wieruszewski","year":"2021","journal-title":"Chest"},{"key":"2025081301371269700_CIT0035","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/CCM.0000000000000333","article-title":"Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock","volume":"42","author":"Anantasit","year":"2014","journal-title":"Crit Care Med"},{"key":"2025081301371269700_CIT0036","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2025081301371269700_CIT0037","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1177\/08850666221081836","article-title":"Influence of timing and catecholamine requirements on vasopressin responsiveness in critically ill patients with septic shock","volume":"37","author":"Jakowenko","year":"2022","journal-title":"J Intensive Care Med"},{"key":"2025081301371269700_CIT0038","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1164\/rccm.200903-0332OC","article-title":"Beta2-adrenergic receptor gene polymorphism is associated with mortality in septic shock","volume":"181","author":"Nakada","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2025081301371269700_CIT0039","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/CCM.0000000000005317","article-title":"Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock","volume":"50","author":"Sacha","year":"2022","journal-title":"Crit Care Med"},{"key":"2025081301371269700_CIT0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13054-019-2420-y","article-title":"Broad spectrum vasopressors: a new approach to the initial management of septic shock","volume":"23","author":"Chawla","year":"2019","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0041","first-page":"101193","article-title":"Multimodal strategy to counteract vasodilation in septic shock","volume":"42","author":"Leone","year":"2023","journal-title":"Anaesth Crit Care Pain Med"},{"key":"2025081301371269700_CIT0042","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/10600280221096886","article-title":"Comment: does early vasopressin in septic shock improve outcomes? An important piece to this emerging puzzle has arrived","volume":"58","author":"McCloskey","year":"2024","journal-title":"Ann Pharmacother"},{"key":"2025081301371269700_CIT0043","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13054-022-03911-7","article-title":"Vasopressor choice and timing in vasodilatory shock","volume":"26","author":"Wieruszewski","year":"2022","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0044","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/CCM.0000000000005344","article-title":"Early multimodal vasopressors\u2014are we ready for it","volume":"50","author":"Wieruszewski","year":"2022","journal-title":"Crit Care Med"},{"key":"2025081301371269700_CIT0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s13054-022-04255-y","article-title":"A plea for personalization of the hemodynamic management of septic shock","volume":"26","author":"De Backer","year":"2022","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0046","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13054-023-04593-5","article-title":"Evidence for a personalized early start of norepinephrine in septic shock","volume":"27","author":"Monnet","year":"2023","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0047","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13054-018-2129-3","article-title":"Hemodynamic management of critically ill burn patients: an international survey","volume":"22","author":"Soussi","year":"2018","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0048","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/aas.14095","article-title":"Vasoactive and\/or inotropic drugs in initial resuscitation of burn injuries: a systematic review","volume":"66","author":"Knappskog","year":"2022","journal-title":"Acta Anaesthesiol Scand"},{"key":"2025081301371269700_CIT0049","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1093\/jbcr\/irz013.141","article-title":"Evaluation of vasopressor use during acute burn fluid resuscitation","volume":"40","author":"Pape","year":"2019","journal-title":"J Burn Care Res"},{"key":"2025081301371269700_CIT0050","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1097\/00003246-200211000-00006","article-title":"Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients","volume":"30","author":"Gore","year":"2002","journal-title":"Crit Care Med"},{"key":"2025081301371269700_CIT0051","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/SLA.0000000000001807","article-title":"Neutrophil dysfunction, immature granulocytes, and cell-free DNA are early biomarkers of sepsis in burn-injured patients: a prospective observational cohort study","volume":"265","author":"Hampson","year":"2017","journal-title":"Ann Surg"},{"key":"2025081301371269700_CIT0052","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1067\/msy.2000.108059","article-title":"Persistence of muscle catabolism after severe burn","volume":"128","author":"Hart","year":"2000","journal-title":"Surgery"},{"key":"2025081301371269700_CIT0053","doi-asserted-by":"crossref","first-page":"e21245","DOI":"10.1371\/journal.pone.0021245","article-title":"Long-term persistance of the pathophysiologic response to severe burn injury","volume":"6","author":"Jeschke","year":"2011","journal-title":"PLoS One"},{"key":"2025081301371269700_CIT0054","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/SHK.0000000000000404","article-title":"Burn-evoked reactive oxygen species immediately after injury are crucial to restore the neutrophil function against postburn infection in mice","volume":"44","author":"Miyazaki","year":"2015","journal-title":"Shock"},{"key":"2025081301371269700_CIT0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00005373-199102000-00015","article-title":"Differential regulation of T- and B-lymphocyte activation in severely burned patients","volume":"31","author":"Schluter","year":"1991","journal-title":"J Trauma"},{"key":"2025081301371269700_CIT0056","first-page":"199","article-title":"Defective antigen presentation to a cloned t helper cell by macrophages from burned mice can be restored with interleukin-1","volume":"98","author":"Kupper","year":"1985","journal-title":"Surgery"},{"key":"2025081301371269700_CIT0057","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025081301371269700_CIT0058","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/TA.0000000000000905","article-title":"Early leukocyte gene expression associated with age, burn size, and inhalation injury in severely burned adults","volume":"80","author":"Sood","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"key":"2025081301371269700_CIT0059","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/SHK.0b013e3181b92340","article-title":"Extent and magnitude of catecholamine surge in pediatric burned patients","volume":"33","author":"Kulp","year":"2010","journal-title":"Shock"},{"key":"2025081301371269700_CIT0060","doi-asserted-by":"crossref","first-page":"100709","DOI":"10.1016\/j.cpsurg.2019.100709","article-title":"Current problems in burn hypermetabolism","volume":"57","author":"Sommerhalder","year":"2020","journal-title":"Curr Probl Surg"},{"key":"2025081301371269700_CIT0061","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/BCR.0b013e31820aafcf","article-title":"Changes in cardiac physiology after severe burn injury","volume":"32","author":"Williams","year":"2011","journal-title":"J Burn Care Res"},{"key":"2025081301371269700_CIT0062","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.burnso.2023.05.001","article-title":"retrospective analysis of systemic norepinephrine impact on tangential excision and split thickness skin graft outcomes in burn shock patients","volume":"7","author":"John AT","year":"2023","journal-title":"Burns Open"},{"key":"2025081301371269700_CIT0063","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0305-4179(99)00086-8","article-title":"Progression of burn wound depth by systemical application of a vasoconstrictor: an experimental study with a new rabbit model","volume":"25","author":"Knabl","year":"1999","journal-title":"Burns"},{"key":"2025081301371269700_CIT0064","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1164\/rccm.202002-0339OC","article-title":"Norepinephrine dysregulates the immune response and compromises host defense during sepsis","volume":"202","author":"Stolk","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2025081301371269700_CIT0065","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/CM9.0000000000002931","article-title":"Effect of norepinephrine on host immunity and bacterial infection","volume":"137","author":"Wang","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"2025081301371269700_CIT0066","doi-asserted-by":"crossref","first-page":"179057","DOI":"10.1155\/2011\/179057","article-title":"Beta-adrenergic receptor-stimulated cardiac myocyte apoptosis: role of beta1 integrins","volume":"2011","author":"Amin","year":"2011","journal-title":"J Signal Transduct"},{"key":"2025081301371269700_CIT0067","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1113\/expphysiol.2004.027482","article-title":"Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways","volume":"89","author":"Goldspink","year":"2004","journal-title":"Exp Physiol"},{"key":"2025081301371269700_CIT0068","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.HYP.0000258703.36986.13","article-title":"Beta1 integrins modulate beta-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling","volume":"49","author":"Krishnamurthy","year":"2007","journal-title":"Hypertension"},{"key":"2025081301371269700_CIT0069","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jcp.10024","article-title":"Adrenergic regulation of cardiac myocyte apoptosis","volume":"189","author":"Singh","year":"2001","journal-title":"J Cell Physiol"},{"key":"2025081301371269700_CIT0070","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.BCR.0000235466.57137.f2","article-title":"Evolution of burn resuscitation in operation Iraqi freedom","volume":"27","author":"Chung","year":"2006","journal-title":"J Burn Care Res"},{"key":"2025081301371269700_CIT0071","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/BCR.0000000000000374","article-title":"Cardiovascular responsiveness to vasopressin and alpha1-adrenergic receptor agonists after burn injury","volume":"38","author":"Evans","year":"2017","journal-title":"J Burn Care Res"},{"key":"2025081301371269700_CIT0072","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.burns.2006.08.012","article-title":"Vasopressin for the septic burn patient","volume":"33","author":"Cartotto","year":"2007","journal-title":"Burns"},{"key":"2025081301371269700_CIT0073","first-page":"e40725","article-title":"Renin-angiotensin system: updated understanding and role in physiological and pathophysiological states","volume":"15","author":"Kanugula","year":"2023","journal-title":"Cureus"},{"key":"2025081301371269700_CIT0074","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/diagnostics13010016","article-title":"A new perspective on the renin-angiotensin system","volume":"13","author":"Martyniak","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2025081301371269700_CIT0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature22035","article-title":"Structural basis for selectivity and diversity in angiotensin II receptors","volume":"544","author":"Zhang","year":"2017","journal-title":"Nature"},{"key":"2025081301371269700_CIT0076","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccc.2018.11.002","article-title":"Classic and nonclassic renin-angiotensin systems in the critically ill","volume":"35","author":"Bitker","year":"2019","journal-title":"Crit Care Clin"},{"key":"2025081301371269700_CIT0077","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/CCM.0000000000006095","article-title":"Association of active renin content with mortality in critically ill patients: a post hoc analysis of the vitamin C, thiamine, and steroids in sepsis trial","volume":"52","author":"Busse","year":"2023","journal-title":"Crit Care Med"},{"key":"2025081301371269700_CIT0078","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13054-018-2202-y","article-title":"Angiotensin converting enzyme defects in shock: implications for future therapy","volume":"22","author":"Chawla","year":"2018","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0079","first-page":"59","article-title":"Angiotensin-converting enzyme (ACE) in sepsis","volume":"11","author":"Rice","year":"1983","journal-title":"Circ Shock"},{"key":"2025081301371269700_CIT0080","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3892\/etm.2014.1566","article-title":"Severe sepsis: low expression of the renin-angiotensin system is associated with poor prognosis","volume":"7","author":"Zhang","year":"2014","journal-title":"Exp Ther Med"},{"key":"2025081301371269700_CIT0081","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1213\/ANE.0000000000006682","article-title":"Renin as a prognostic marker in intensive care and perioperative settings: a scoping review","volume":"138","author":"Kotani","year":"2023","journal-title":"Anesth Analg"},{"key":"2025081301371269700_CIT0082","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1164\/rccm.202005-2050OC","article-title":"Kinetic changes of plasma renin concentrations predict acute kidney injury in cardiac surgery patients","volume":"203","author":"Kullmar","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2025081301371269700_CIT0083","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1213\/ANE.0000000000005953","article-title":"The association between angiotensin II and renin kinetics in patients after cardiac surgery","volume":"134","author":"Meersch","year":"2022","journal-title":"Anesth Analg"},{"key":"2025081301371269700_CIT0084","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.jvca.2022.11.019","article-title":"Plasma renin activity increases with cardiopulmonary bypass and is associated with vasoplegia after cardiac surgery","volume":"37","author":"Montgomery","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025081301371269700_CIT0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/CCM.0000000000005143","article-title":"Renin kinetics are superior to lactate kinetics for predicting in-hospital mortality in hypotensive critically ill patients","volume":"50","author":"Jeyaraju","year":"2022","journal-title":"Crit Care Med"},{"key":"2025081301371269700_CIT0086","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13054-020-2733-x","article-title":"Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock","volume":"24","author":"Bellomo","year":"2020","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0087","first-page":"61","article-title":"Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study","author":"Blet","year":"2021"},{"key":"2025081301371269700_CIT0088","doi-asserted-by":"crossref","first-page":"e0238039","DOI":"10.1371\/journal.pone.0238039","article-title":"Inhibition of circulating dipeptidyl-peptidase 3 restores cardiac function in a sepsis-induced model in rats: a proof of concept study","volume":"15","author":"Deniau","year":"2020","journal-title":"PLoS One"},{"key":"2025081301371269700_CIT0089","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1164\/rccm.202010-3873LE","article-title":"Alteration of the renin-angiotensin-aldosterone system in shock: role of the dipeptidyl peptidase 3","volume":"203","author":"Picod","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2025081301371269700_CIT0090","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1373\/jalm.2018.027995","article-title":"Novel methods for the quantification of dipeptidyl peptidase 3 (DPP3) concentration and activity in human blood samples","volume":"3","author":"Rehfeld","year":"2019","journal-title":"J Appl Lab Med"},{"key":"2025081301371269700_CIT0091","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/00365597209133633","article-title":"Studies on burns. XIV. Plasma renin activity correlated to renal function in burned patients","volume":"6","author":"Bozovic","year":"1972","journal-title":"Scand J Urol Nephrol"},{"key":"2025081301371269700_CIT0092","first-page":"166","article-title":"Plasma renin like activity (RLA) and angiotensin II levels after major burns. A preliminary report","volume":"15","author":"Dolecek","year":"1973","journal-title":"Acta Chir Plast"},{"key":"2025081301371269700_CIT0093","first-page":"212","article-title":"Observations on the activity of the renin-angiotensin-aldosterone (RAA) system after low volume colloid resuscitation for burn injury","volume":"65","author":"Griffiths","year":"1983","journal-title":"Ann R Coll Surg Engl"},{"key":"2025081301371269700_CIT0094","first-page":"518","article-title":"Circadian rhythms of serum aldosterone, cortisol and plasma renin activity in burn injuries","volume":"9","author":"Molteni","year":"1979","journal-title":"Ann Clin Lab Sci"},{"key":"2025081301371269700_CIT0095","first-page":"331","article-title":"Renin signals renal hypoperfusion during parkland fluid resuscitation of severe burns \u2013 a prospective longitudinal cohort study","volume":"10","author":"Vieweg","year":"2020","journal-title":"Int J Burns Trauma"},{"key":"2025081301371269700_CIT0096","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13054-020-02888-5","article-title":"Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients","volume":"24","author":"Depret","year":"2020","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0097","doi-asserted-by":"crossref","first-page":"13711","DOI":"10.1074\/jbc.RA120.014183","article-title":"Dipeptidyl peptidase 3 modulates the renin-angiotensin system in mice","volume":"295","author":"Jha","year":"2020","journal-title":"J Biol Chem"},{"key":"2025081301371269700_CIT0098","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biopha.2009.01.001","article-title":"Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice","volume":"63","author":"Kurosaka","year":"2009","journal-title":"Biomed Pharmacother"},{"key":"2025081301371269700_CIT0099","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13069-015-0023-z","article-title":"Modulation of angiotensin II signaling in the prevention of fibrosis","volume":"8","author":"Murphy","year":"2015","journal-title":"Fibrogenesis Tissue Rep"},{"key":"2025081301371269700_CIT0100","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2133.2005.06806.x","article-title":"Differential expression of angiotensin receptors in human cutaneous wound healing","volume":"153","author":"Steckelings","year":"2005","journal-title":"Br J Dermatol"},{"key":"2025081301371269700_CIT0101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1524-475X.2012.00867.x","article-title":"Effects of combined radiation and burn injury on the renin-angiotensin system","volume":"21","author":"Jadhav","year":"2013","journal-title":"Wound Repair Regen"},{"key":"2025081301371269700_CIT0102","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jash.2014.05.014","article-title":"Physiology: hemodynamics, endothelial function, renin-angiotensin-aldosterone system, sympathetic nervous system","volume":"8","author":"Navar","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"2025081301371269700_CIT0103","doi-asserted-by":"crossref","first-page":"R190","DOI":"10.1186\/cc8185","article-title":"Angiotensin II in experimental hyperdynamic sepsis","volume":"13","author":"Wan","year":"2009","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0104","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"2025081301371269700_CIT0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","article-title":"Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial","volume":"27","author":"Wieruszewski","year":"2023","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0106","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13054-022-04161-3","article-title":"Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock","volume":"26","author":"Garcia","year":"2022","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0107","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/SHK.0000000000002109","article-title":"A pilot study of angiotensin II as primary vasopressor in critically ill adults with vasodilatory hypotension: the ARAMIS study","volume":"59","author":"See","year":"2023","journal-title":"Shock"},{"key":"2025081301371269700_CIT0108","doi-asserted-by":"crossref","first-page":"e2211370119","DOI":"10.1073\/pnas.2211370119","article-title":"Angiotensin II enhances bacterial clearance via myeloid signaling in a murine sepsis model","volume":"119","author":"Leisman","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025081301371269700_CIT0109","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1524-475x.2001.00238.x","article-title":"Development of angiotensin (1-7) as an agent to accelerate dermal repair","volume":"9","author":"Rodgers","year":"2001","journal-title":"Wound Repair Regen"},{"key":"2025081301371269700_CIT0110","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.0906-6705.2003.00087.x","article-title":"Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice","volume":"12","author":"Rodgers","year":"2003","journal-title":"Exp Dermatol"},{"key":"2025081301371269700_CIT0111","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0002-9440(10)63422-0","article-title":"Effects of angiotensin II receptor signaling during skin wound healing","volume":"165","author":"Takeda","year":"2004","journal-title":"Am J Pathol"},{"key":"2025081301371269700_CIT0112","first-page":"124","article-title":"The change of angiotensin II production and its receptor expression during wound healing: possible role of angiotensin II in wound healing","volume":"27","author":"Wu","year":"2011","journal-title":"Zhonghua Zheng Xing Wai Ke Za Zhi"},{"key":"2025081301371269700_CIT0113","doi-asserted-by":"crossref","first-page":"104709","DOI":"10.1016\/j.mvr.2024.104709","article-title":"Synthetic angiotensin II ameliorates alterations of systemic hemodynamics, microcirculatory deterioration, and renal damage in septic rats","volume":"155","author":"Ergin","year":"2024","journal-title":"Microvasc Res"},{"key":"2025081301371269700_CIT0114","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1524-475X.1997.50210.x","article-title":"Acceleration of dermal tissue repair by angiotensin II","volume":"5","author":"Rodgers","year":"1997","journal-title":"Wound Repair Regen"},{"key":"2025081301371269700_CIT0115","first-page":"732","article-title":"Potential use of angiotensin receptor blockers in skin pathologies","volume":"26","author":"Hedayatyanfard","year":"2023","journal-title":"Iran J Basic Med Sci"},{"key":"2025081301371269700_CIT0116","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.shk.0000230302.24258.9f","article-title":"Blockade of the renin-angiotensin system improves insulin sensitivity in thermal injury","volume":"26","author":"Kasper","year":"2006","journal-title":"Shock"},{"key":"2025081301371269700_CIT0117","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/SHK.0b013e3181e762da","article-title":"Blockade of the renin-angiotensin system improves insulin receptor signaling and insulin-stimulated skeletal muscle glucose transport in burn injury","volume":"35","author":"Kasper","year":"2011","journal-title":"Shock"},{"key":"2025081301371269700_CIT0118","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5505\/tjtes.2014.96493","article-title":"Captopril protects against burn-induced cardiopulmonary injury in rats","volume":"20","author":"Saglam","year":"2014","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"2025081301371269700_CIT0119","first-page":"366","article-title":"The effect of captopril on brain apoptosis after burn injury in rats","volume":"23","author":"Saglam","year":"2013","journal-title":"Turk Neurosurg"},{"key":"2025081301371269700_CIT0120","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0121","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"key":"2025081301371269700_CIT0122","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13613-023-01227-5","article-title":"Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock","volume":"13","author":"Leisman","year":"2023","journal-title":"Ann Intensive Care"},{"key":"2025081301371269700_CIT0123","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1177\/08850666231174870","article-title":"Trajectory of PaO2\/ FiO2 ratio in shock after angiotensin II","volume":"38","author":"Wieruszewski","year":"2023","journal-title":"J Intensive Care Med"},{"key":"2025081301371269700_CIT0124","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.jvca.2020.08.001","article-title":"Treatment with angiotensin II is associated with rapid blood pressure response and vasopressor sparing in patients with vasoplegia after cardiac surgery: a post-hoc analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) study","volume":"35","author":"Klijian","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025081301371269700_CIT0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/10600280221099928","article-title":"Evaluation of the addition of angiotensin II in patients with shock after cardiac surgery at a veterans affairs medical center","volume":"57","author":"Bird","year":"2023","journal-title":"Ann Pharmacother"},{"key":"2025081301371269700_CIT0126","first-page":"e0623","article-title":"Effectiveness of angiotensin II for catecholamine refractory septic or distributive shock on mortality: a propensity score weighted analysis of real-world experience in the medical ICU","volume":"4","author":"Quan","year":"2022","journal-title":"Crit Care Explor"},{"key":"2025081301371269700_CIT0127","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0885066620972943","article-title":"A multicenter observational cohort study of angiotensin II in shock","volume":"37","author":"Smith","year":"2022","journal-title":"J Intensive Care Med"},{"key":"2025081301371269700_CIT0128","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1177\/0885066619872720","article-title":"A retrospective review of angiotensin II use in adult patients with refractory distributive shock","volume":"35","author":"Wong","year":"2020","journal-title":"J Intensive Care Med"},{"key":"2025081301371269700_CIT0129","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/aca.aca_98_21","article-title":"Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: a case series","volume":"25","author":"Konkol","year":"2022","journal-title":"Ann Card Anaesth"},{"key":"2025081301371269700_CIT0130","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1097\/CCM.0000000000005975","article-title":"Angiotensin II for the treatment of refractory shock: a matched analysis","volume":"51","author":"Smith","year":"2023","journal-title":"Crit Care Med"},{"key":"2025081301371269700_CIT0131","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1513\/AnnalsATS.202306-540RL","article-title":"Adoption of a novel vasopressor agent in critically ill adults","volume":"20","author":"Vail","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"2025081301371269700_CIT0132","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/08850666221145864","article-title":"Angiotensin II for vasodilatory hypotension in patients requiring mechanical circulatory support","volume":"38","author":"Wieruszewski","year":"2023","journal-title":"J Intensive Care Med"},{"key":"2025081301371269700_CIT0133","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/anae.15802","article-title":"A double-blind randomised feasibility trial of angiotensin-2 in cardiac surgery","volume":"77","author":"Coulson","year":"2022","journal-title":"Anaesthesia"},{"key":"2025081301371269700_CIT0134","first-page":"419","article-title":"Prothrombotic effects of angiotensin","volume":"45","author":"Brown","year":"2000","journal-title":"Adv Intern Med"},{"key":"2025081301371269700_CIT0135","volume-title":"Giapreza (Angiotensin II) [Package Insert]","year":"2021"},{"key":"2025081301371269700_CIT0136","volume-title":"Angiotensin II for the Treatment of Vasodilatory Shock ATHOS-3 Post-Hoc Analysis: Severity and Temporal Relationship of Venous Thromboembolic Events. Unpublished Raw Data on File","year":"2021"},{"key":"2025081301371269700_CIT0137","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.bjps.2020.12.011","article-title":"Venous thromboembolism in burns patients: are we underestimating the risk and underdosing our prophylaxis?","volume":"74","author":"Lu","year":"2021","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2025081301371269700_CIT0138","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/jbcr\/iraa143","article-title":"Venous thromboembolism chemoprophylaxis in burn patients: a literature review and single-institution experience","volume":"42","author":"Liu","year":"2021","journal-title":"J Burn Care Res"},{"key":"2025081301371269700_CIT0139","doi-asserted-by":"crossref","first-page":"653.e9","DOI":"10.1016\/j.jcrc.2015.01.014","article-title":"A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters","volume":"30","author":"Loubani","year":"2015","journal-title":"J Crit Care"},{"key":"2025081301371269700_CIT0140","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13054-021-03553-1","article-title":"Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis","volume":"25","author":"Owen","year":"2021","journal-title":"Crit Care"},{"key":"2025081301371269700_CIT0141","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/1742-6723.13406","article-title":"Safety of peripheral administration of vasopressor medications: a systematic review","volume":"32","author":"Tian","year":"2020","journal-title":"Emerg Med Australas"},{"key":"2025081301371269700_CIT0142","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1513\/AnnalsATS.202203-197RL","article-title":"Hospital policies on intravenous vasopressor administration and monitoring: a survey of Michigan hospitals","volume":"19","author":"Munroe","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2025081301371269700_CIT0143","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/phar.2794","article-title":"Management of noncytotoxic extravasation injuries: a focused update on medications, treatment strategies, and peripheral administration of vasopressors and hypertonic saline","volume":"43","author":"Stefanos","year":"2023","journal-title":"Pharmacotherapy"},{"key":"2025081301371269700_CIT0144","volume-title":"Intravenous Administration of Angiotensin II via Peripheral Venous Catheter","year":"2021"},{"key":"2025081301371269700_CIT0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bja.2024.04.061","article-title":"Angiotensin II treatment of hypotension in noncardiac surgery: an initial dose-finding study","volume":"133","author":"Fernando","year":"2024","journal-title":"Br J Anaesth"},{"key":"2025081301371269700_CIT0146","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00005373-197101000-00003","article-title":"Hemodynamic changes in the early postburn patient: the influence of fluid administration and of a vasodilator (hydralazine)","volume":"11","author":"Pruitt","year":"1971","journal-title":"J Trauma"},{"key":"2025081301371269700_CIT0147","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajem.2023.01.050","article-title":"Efficacy and safety of angiotensin II in cardiogenic shock: a systematic review","volume":"66","author":"Bansal","year":"2023","journal-title":"Am J Emerg Med"},{"key":"2025081301371269700_CIT0148","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/CCM.0000000000002441","article-title":"Clinical experience with IV angiotensin II administration: a systematic review of safety","volume":"45","author":"Busse","year":"2017","journal-title":"Crit Care Med"},{"key":"2025081301371269700_CIT0149","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41038-018-0131-2","article-title":"Weight changes and patterns of weight measurements in hospitalized burn patients: a contemporary analysis","volume":"6","author":"Mendez-Romero","year":"2018","journal-title":"Burns Trauma"},{"key":"2025081301371269700_CIT0150","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/SLA.0000000000005166","article-title":"Burn resuscitation practices in North America: results of the Acute Burn Resuscitation Multicenter Prospective Trial (ABRUPT)","volume":"277","author":"Greenhalgh","year":"2023","journal-title":"Ann Surg"},{"key":"2025081301371269700_CIT0151","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.burns.2024.03.007","article-title":"Precursors to oliguria during major burn resuscitation: an analysis of a prospective observational trial at 5 major US burn centers","volume":"50","author":"McHargue","year":"2024","journal-title":"Burns"},{"key":"2025081301371269700_CIT0152","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cps.2009.05.001","article-title":"The hypermetabolic response to burn injury and interventions to modify this response","volume":"36","author":"Williams","year":"2009","journal-title":"Clin Plast Surg"},{"key":"2025081301371269700_CIT0153","first-page":"1013","article-title":"Efficacy of propranolol in wound healing for hospitalized burn patients","volume":"30","author":"Mohammadi","year":"2009","journal-title":"J Burn Care Res"},{"key":"2025081301371269700_CIT0154","doi-asserted-by":"crossref","first-page":"tkad063","DOI":"10.1093\/burnst\/tkad063","article-title":"Administration and effects of beta blockers and oxandrolone in severely burned adults: a post hoc analysis of the re-energize trial","volume":"12","author":"Hundeshagen","year":"2024","journal-title":"Burns Trauma"}],"container-title":["Journal of Burn Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbcr\/advance-article-pdf\/doi\/10.1093\/jbcr\/irae208\/61136764\/irae208.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbcr\/article-pdf\/46\/3\/515\/61136764\/irae208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbcr\/article-pdf\/46\/3\/515\/61136764\/irae208.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T05:37:35Z","timestamp":1755063455000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbcr\/article\/46\/3\/515\/7922966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":154,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,12,13]]},"published-print":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.1093\/jbcr\/irae208","relation":{},"ISSN":["1559-047X","1559-0488"],"issn-type":[{"value":"1559-047X","type":"print"},{"value":"1559-0488","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,12,13]]}}}